Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort-Reference-Cited by-同舟云学术

Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort

Published:2020-06 Issue: Volume:23 Page:100581
ISSN:2214-4269
Container-title:Molecular Genetics and Metabolism Reports
language:en
Short-container-title:Molecular Genetics and Metabolism Reports

Author:

Wicker Camille,Roda Célina,Perry Ariane,Arnoux Jean Baptiste,Brassier Anais,Castelle Martin,Servais Aude,Donadieu Jean,Bouchereau Juliette,Pigneur Bénédicte,Labrune Philippe,Ruemmele Frank M.,de Lonlay Pascale

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology

Reference28 articles.

1. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I);Rake;Eur. J. Pediatr.,2002

2. Glucose-6-phosphatase deficiency;Froissart;Orphanet J. Rare Dis.,2011

3. Glycogen storage disease type I and G6Pase-β deficiency: Etiology and therapy;Chou;Nat. Rev. Endocrinol.,2010

4. Neutropenia in type Ib glycogen storage disease;Chou;Curr. Opin. Hematol.,2010

5. Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib;Kim;Blood.,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Pediatric Liver Transplantation in Glycogen Storage Disease Type 1b—A Single‐Center Experience;Pediatric Transplantation;2024-08-30

2. Current Clinical Guidelines for the Management of Patients with Glycogen Storage Disease;Pediatric pharmacology;2024-07-04

3. Gut Dysbiosis Drives Inflammatory Bowel Disease Through the CCL4L2‐VSIR Axis in Glycogen Storage Disease;Advanced Science;2024-06-18

4. Empagliflozin in children with glycogen storage disease-associated inflammatory bowel disease: a prospective, single-arm, open-label clinical trial;Scientific Reports;2024-04-15

5. Glycogen storage disease type Ib: modern understanding of the pathogenesis of neutropenia and prospects for its treatment with empagliflozin;Pediatric pharmacology;2023-11-17